Skip to main content
Log in

Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients

  • ORIGINAL PAPER
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Objective

The lack of nocturnal decline in blood pressure (BP) is associated with an increase in cardiovascular events. Soluble CD40 ligand (sCD40L) is involved in the pathogenesis of risk factor-related vascular damage. The purpose of this study was to examine the relationship between vascular endothelial functions, carotid intima-media thickness (cIMT), plasma sCD40L levels and circadian BP profile in patients with essential hypertension.

Material and methods

The study population consisted of 81 essential hypertensive out-patients. BP dipping was defined as a night-to-day systolic and diastolic decrease ≥10%. Forty-seven dipper and 34 nondipper patients were compared. High sensitivity C-reactive protein (hs-CRP), sCD40L and urinary albumin were measured. Brachial artery flow-mediated dilatation (FMD) and cIMT was compared between the groups.

Results

sCD40L level (3.28 ± 2.08 and 2.30 ± 1.99 ng/ml, respectively, P = 0.036) and urinary albumin concentration (36.7 ± 20.1 and 23 ± 29.7 mg/l, respectively, P < 0.0001) were higher in nondippers than in dippers. Serum hs-CRP levels were not significantly different. FMD was found higher in dippers than nondippers (11.8 ± 3.9% and 6.6 ± 2.2%, respectively, P < 0.0001). The average cIMT was significantly higher in nondippers than dippers (0.928 ± 0.060 Vs. 0.734 ± 0.134 mm; P < 0.0001).

Conclusions

Nondipper patern has an additional negative effect on endothelial functions in hypertensive patients. Nondippers have enhanced sCD40L levels, which may contribute to their increased susceptibility to develop vascular damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ahn ER, Lander G, Jy W, Bidot CJ, Jimenez JJ, Horstman LL, Ahn YS (2004) Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res 114:143–148

    Article  PubMed  CAS  Google Scholar 

  2. Andrè P, Nannizzi-Alaimo L, Prasad AK, Phillips DR (2002) Plateletderived CD40L. The switch-hitting player of cardiovascular disease. Circulation 106:896–899

    Article  PubMed  Google Scholar 

  3. Becker BF, Heindl B, Kupatt C, Zahler S (2000) Endothelial function and hemostasis. Z Kardiol 89:160–167

    PubMed  CAS  Google Scholar 

  4. Becker BF, Heindl B, Kupatt C, Zahler S (2000) Endothelial function and hemostasis. Z Kardiol 89(3):160–167

    PubMed  CAS  Google Scholar 

  5. Blann AD, Nadar S, Lip GYH (2003) Pharmacological modulations of platelet function in hypertension. Hypertension 42:1–7

    Article  PubMed  CAS  Google Scholar 

  6. Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 39:257–265

    Article  PubMed  Google Scholar 

  7. Cuspidi C, Macca G, Sampieri L, Fusi V, Severgnini B, Michey I, Salerno M, Magrini F, Zanchetti A (2001) Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed hypertensive patients. J Hypertens 19:1539–1545

    Article  PubMed  CAS  Google Scholar 

  8. Desideri G, Cipollone F, Valeri L, Grassi D, Necozione S, Croce G, Passacquale G, Garofalo A, Lippi C, Mezzetti A, Ferri C (2007) Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease. Am J Hypertens 20:70–76

    Article  PubMed  CAS  Google Scholar 

  9. Devereux RB, Alonso DR, Lutas EM et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458

    Article  PubMed  CAS  Google Scholar 

  10. Duygu H (2007) Endothelial functions and hypertension. J Card Res 5:73–81

    Google Scholar 

  11. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A (2002) Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 25:475–480

    Article  PubMed  Google Scholar 

  12. Gimbrone MA Jr (1995) Vascular endothelium in health and disease. In: Haber E (ed) Molecular cardiovascular medicine, chap 4. Scientific American Medicine, New York, pp 49–61

    Google Scholar 

  13. Henn V, Slupsky JR, Grafe M (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594

    Article  PubMed  CAS  Google Scholar 

  14. Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, Goto C, Oshima T, Chayama K, Yoshizumi M (2002) Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and non-dippers. J Am Coll Cardiol 40:2039–2043

    Article  PubMed  Google Scholar 

  15. Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92:4342–4346

    Article  PubMed  CAS  Google Scholar 

  16. von Känel R, Jain S, Mills PJ, Nelesen RA, Adler KA, Hong S, Perez CJ, Dimsdale JE (2004) Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens 22:2087–2093

    Article  Google Scholar 

  17. Lee KW, Blann AD, Lip GY (2005) High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 18:104–115

    Article  PubMed  Google Scholar 

  18. Lee IK, Kim HS, Bae JH (2002) Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia. Int J Clin Pract Suppl 129:59–64

    PubMed  Google Scholar 

  19. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P (1997) Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96:396–399

    PubMed  CAS  Google Scholar 

  20. Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, Degan M, Faccini G, Fornasiero A, Talamini G, Tommasoli R, Arosio E, Santonastaso CL, Lechi A, Patrono C (2004) Determinants of platelet activation in human essential hypertension. Hypertension 43:64–70

    Article  PubMed  CAS  Google Scholar 

  21. Ohkubo T, Hozawa A, Yamaguchi J et al (2002) Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h high blood pressure: the Ohasama Study. J Hypertens 20:2183–2189

    Article  PubMed  CAS  Google Scholar 

  22. Patel JV, Lim HS, Nadar S, Tayebjee M, Hughes EA, Lip GY (2006) Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis. J Hypertens 24:117–121

    Article  PubMed  CAS  Google Scholar 

  23. Pierdomenico S, Lapenna D, Guglielmi MD, Costantini F, Romano F, Schiavone C, Cuccurullo F, Mezzetti A (1997) Arterial disease in dipper and non-dipper hypertensive patients. Am J Hypertens 10:511–518

    Article  PubMed  CAS  Google Scholar 

  24. Rizzo V, Maio FD, Campbell SV et al (2000) Left ventricular function, cardiac dysrhythmias, atrial activation, and volumes in nondipper hypertensive individuals with left ventricular hypertrophy. Am Heart J 139:529–536

    Article  PubMed  CAS  Google Scholar 

  25. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) The Committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083

    PubMed  CAS  Google Scholar 

  26. Saka B, Oflaz H, Erten N, Bahat G, Dursun M, Pamukcu B, Mercanoglu F, Meric M, Karan MA (2005) Non-invasive evaluation of endothelial function in hypertensive elderly patients. Arch Gerontol Geriatr 40(1):61–71

    Article  PubMed  Google Scholar 

  27. Schonbeck U, Libby P (2001) CD40 signaling and plaque instability. Circ Res 89:1092–1103

    Article  PubMed  CAS  Google Scholar 

  28. Schonbeck U, Libby P (2001) The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58:4–43

    Article  PubMed  CAS  Google Scholar 

  29. Schonbeck U, Mach F, Bonnefoy JY, Loppnow H, Flad HD, Libby P (1997) Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta. J Biol Chem 272:19569–19574

    Article  PubMed  CAS  Google Scholar 

  30. Schonbeck U, Mach F, Sukhova GK, Herman M, Graber P, Kehry MR, Libby P (2000) CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol 156:7–14

    PubMed  CAS  Google Scholar 

  31. Schonbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P (1997) Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 81:448–454

    PubMed  CAS  Google Scholar 

  32. Staessen JA, Thijs L, Fagard R et al (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 282:539–546

    Article  PubMed  CAS  Google Scholar 

  33. Suzuki Y, Kuwajima I, Aono T et al (2000) Prognostic value of nighttime blood pressure in the elderly: a prospective study of 24-hour blood pressure. Hypertens Res 23:323–330

    Article  PubMed  CAS  Google Scholar 

  34. Toledo JC, Tacito LH, Melo SE, Sousa W, Colombo F, Irigoyen MC, Franchini K, Coelho OR, Moreno H (2005) Low-renin (volume dependent) mild-hypertensive patients have impaired flow-mediated and glyceryl-trinitrate stimulated vascular reactivity. Circ J 69(11):1380–1385

    Article  Google Scholar 

  35. Verdecchia P, Borgioni C, Ciucci A et al (1996) Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit 1:3–11

    PubMed  Google Scholar 

  36. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G (1994) Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793–801

    PubMed  CAS  Google Scholar 

  37. Verdecchia P, Schillaci G, Gatteschi C, Zampi I, Battistelli M, Bartoccini C, Porcellati C (1993) Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 88:986–992

    PubMed  CAS  Google Scholar 

  38. Vishnevetsky D, Kiyanista VA, Gandhi PJ (2004) CD40 ligand: a novel target in the fight against cardiovascular disease. Ann Pharmacother 38:1500–1508

    Article  PubMed  CAS  Google Scholar 

  39. Yan JC, Ma GS, Wu ZG, Kong XT, Zong RQ, Zhan LZ (2005) Increased levels of CD40-CD40 ligand system in patients with essential hypertension. Clin Chim Acta 355:191–196

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emin Alioglu MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alioglu, E., Turk, U.O., Bicak, F. et al. Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients. Clin Res Cardiol 97, 457–462 (2008). https://doi.org/10.1007/s00392-008-0654-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-008-0654-9

Keywords

Navigation